KCNK9 Antikörper
-
- Target Alle KCNK9 Antikörper anzeigen
- KCNK9 (Potassium Channel, Subfamily K, Member 9 (KCNK9))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KCNK9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human KCNK9
- Isotyp
- IgG
- Top Product
- Discover our top product KCNK9 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:100-1:300
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- KCNK9 (Potassium Channel, Subfamily K, Member 9 (KCNK9))
- Andere Bezeichnung
- KCNK9 (KCNK9 Produkte)
- Hintergrund
- This gene encodes a protein that contains multiple transmembrane regions and two pore-forming P domains and functions as a pH -dependent potassium channel. Amplification and overexpression of this gene have been observed in several types of human carcinomas. This gene is imprinted in the brain, with preferential expression from the maternal allele. A mutation in this gene was associated with Birk-Barel mental retardation dysmorphism syndrome. Alternative splicing results in multiple transcript variants.
- Molekulargewicht
- 42 kDa
- NCBI Accession
- NP_001269463
- UniProt
- Q9NPC2
-